Novo Nordisk slashes Wegovy prices in India by up to 37% to boost sluggish sales of weight-loss drug
Danish pharma company Novo Nordisk has cut the price of its flagship diabetes and weight loss brand Wegovy (semaglutide) by up to 37% across dosages in India, according to industry sources. With the current price cut – that ranges between 20-37% – Wegovy injections will cost Rs 10,850 for the lowest dose of 0.25 mg,…